files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in
146
Views
7
Downloads

Prevalence and Management of Dry Eye Syndrome in Patients Undergoing Topical Anti‐Glaucoma Treatment

S.A. Arsha Ressal, R. Jeyanthi, Biju Gopal, Rajeevan , Kishore , Hannah Shiny, Mathew Tony, Rinita , S. Veeralakshmanan, Vaduva Krishnan, R. Aalathi, Niranjana Prabha, Sodestti Venkata Anjani Kumar and Shyam Sangeeth
Page: 301-306 | Received 05 Jan 2024, Published online: 18 Feb 2024

Download Citation
https://doi.org/10.36478/10.36478/makrjms.2024.1.301.306

Full Text Reference XML File PDF File

Abstract

Glaucoma, a chronic optic neuropathy, necessitates lowering intralobular pressure (IOP) through topical anti‐glaucoma medications. Despite their efficacy, these medications may induce Dry Eye Syndrome (DES), impacting ocular surface health. This study aims to investigate DES prevalence and management in patients undergoing topical anti‐glaucoma treatment. Objectives include determining prevalence, evaluating symptom severity assessing management effectiveness. A cross‐sectional study involved 500 glaucoma patients using Prostaglandin Analogues, Beta Blockers, Alpha Agonists, Carbonic Anhydrase Inhibitors, or Combination Therapy. Prevalence was assessed clinically, symptoms were quantified via questionnaires diagnostic tests (Schirmer, TBUT, staining) were employed. Management strategies were evaluated for efficacy. DES prevalence varied: Combination Therapy (50%) and Prostaglandin Analogues (45%) exhibited highest rates. Symptomatology highlighted burning sensation (102 cases) and foreign body sensation (82 cases). Diagnostic tests indicated poorer outcomes in Combination Therapy. Effective management included Combination Therapy (90% symptom improvement) and Punctal Plugs (80%). DES prevalence and severity vary with medication type, impacting patient symptoms and diagnostic outcomes. Effective management strategies include tailored therapies, but further research is warranted to refine treatment approaches.

How to cite this article:

S.A. Arsha Ressal, R. Jeyanthi, Biju Gopal, Rajeevan , Kishore , Hannah Shiny, Mathew Tony, Rinita , S. Veeralakshmanan, Vaduva Krishnan, R. Aalathi, Niranjana Prabha, Sodestti Venkata Anjani Kumar and Shyam Sangeeth. Prevalence and Management of Dry Eye Syndrome in Patients Undergoing Topical Anti‐Glaucoma Treatment.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.1.301.306
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.1.301.306